Your browser doesn't support javascript.
loading
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer.
Compadre, Amanda J; van Biljon, Lillian N; Valentine, Mark C; Llop-Guevara, Alba; Graham, Emily; Fashemi, Bisiayo; Herencia-Ropero, Andrea; Kotnik, Emilee N; Cooper, Isaac; Harrington, Shariska P; Kuroki, Lindsay M; McCourt, Carolyn K; Hagemann, Andrea R; Thaker, Premal H; Mutch, David G; Powell, Matthew A; Sun, Lulu; Mosammaparast, Nima; Serra, Violeta; Zhao, Peinan; Lomonosova, Elena; Khabele, Dineo; Mullen, Mary M.
Afiliação
  • Compadre AJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • van Biljon LN; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Valentine MC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Llop-Guevara A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Graham E; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Fashemi B; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Herencia-Ropero A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Kotnik EN; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain.
  • Cooper I; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Harrington SP; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Kuroki LM; Minnesota Oncology, St. Paul, Minnesota.
  • McCourt CK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Hagemann AR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Thaker PH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Mutch DG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Powell MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Sun L; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Mosammaparast N; Department of Pathology and Immunology, Washington University, St. Louis, Missouri.
  • Serra V; Department of Pathology and Immunology, Washington University, St. Louis, Missouri.
  • Zhao P; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Lomonosova E; Department of Obstetrics and Gynecology, Center for Reproductive Health Sciences, Washington University, St Louis, Missouri.
  • Khabele D; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
  • Mullen MM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University, St Louis, Missouri.
Clin Cancer Res ; 29(13): 2466-2479, 2023 07 05.
Article em En | MEDLINE | ID: mdl-37097615

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Platina Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Platina Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article